BioPharma Credit (LON:BPCR) Reaches New 1-Year High – Still a Buy?

BioPharma Credit (LON:BPCRGet Free Report)’s stock price reached a new 52-week high during trading on Wednesday . The stock traded as high as GBX 1 and last traded at GBX 0.97, with a volume of 1882905 shares changing hands. The stock had previously closed at GBX 0.96.

BioPharma Credit Price Performance

The stock has a market cap of £10.68 million, a price-to-earnings ratio of 0.08 and a beta of 0.22. The firm has a fifty day moving average of GBX 0.94 and a 200 day moving average of GBX 0.93.

About BioPharma Credit

(Get Free Report)

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.

Featured Stories

Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.